The prevalence and prognostic value of BRAF mutation in thyroid cancer
E Kebebew, J Weng, J Bauer, G Ranvier… - Annals of …, 2007 - journals.lww.com
Objective: To examine the prevalence of BRAF mutation among thyroid cancer histologic
subtypes and determine the association of BRAF mutation with indicators of poor prognosis …
subtypes and determine the association of BRAF mutation with indicators of poor prognosis …
Higher rate of BRAF mutation in papillary thyroid cancer over time A single‐institution study
A Mathur, W Moses, R Rahbari, E Khanafshar… - Cancer, 2011 - Wiley Online Library
BACKGROUND: The incidence of thyroid cancer has doubled over the past decade. The
reason for this dramatic increase in incidence is controversial. Some investigators have …
reason for this dramatic increase in incidence is controversial. Some investigators have …
Clinicopathologic Implications of the BRAFV600E Mutation in Papillary Thyroid Cancer: A Subgroup Analysis of 3130 Cases in a Single Center
JY Lim, SW Hong, YS Lee, BW Kim, CS Park… - Thyroid, 2013 - liebertpub.com
Background: The BRAF mutation has been shown to be associated with aggressive
clinicopathologic characteristics of papillary thyroid cancer (PTC). However, several studies …
clinicopathologic characteristics of papillary thyroid cancer (PTC). However, several studies …
BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer
Abstract Background The BRAF V600E mutation is the most common genetic alteration
found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more …
found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more …
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
M Xing, WH Westra, RP Tufano, Y Cohen… - The Journal of …, 2005 - academic.oup.com
Context: Use of BRAF mutation in papillary thyroid cancer (PTC) has the potential to improve
risk stratification of this cancer. Objective: The objective of the study was to investigate the …
risk stratification of this cancer. Objective: The objective of the study was to investigate the …
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma
C Lupi, R Giannini, C Ugolini, A Proietti… - The Journal of …, 2007 - academic.oup.com
Context: Because very few studies have examined the correlation between BRAF mutations
and clinicopathological features of papillary thyroid carcinoma (PTC), we analyzed here a …
and clinicopathological features of papillary thyroid carcinoma (PTC), we analyzed here a …
Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation
L Yip, MN Nikiforova, SE Carty, JH Yim, MT Stang… - Surgery, 2009 - Elsevier
BACKGROUND: To date, a mutation of the BRAF oncogene is the most common genetic
alteration found in papillary thyroid carcinoma (PTC) and is associated with extrathyroidal …
alteration found in papillary thyroid carcinoma (PTC) and is associated with extrathyroidal …
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
M Xing, AS Alzahrani, KA Carson, YK Shong… - Journal of clinical …, 2015 - ascopubs.org
Purpose To investigate the prognostic value of BRAF V600E mutation for the recurrence of
papillary thyroid cancer (PTC). Patients and Methods This was a retrospective multicenter …
papillary thyroid cancer (PTC). Patients and Methods This was a retrospective multicenter …
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of …
Y Ito, H Yoshida, R Maruo, S Morita, T Takano… - Endocrine …, 2009 - jstage.jst.go.jp
Recent studies have demonstrated that BRAFV600E mutation is a common event in
papillary thyroid carcinoma and a majority of these lesions have shown a direct relationship …
papillary thyroid carcinoma and a majority of these lesions have shown a direct relationship …
BRAF mutation is not predictive of long‐term outcome in papillary thyroid carcinoma
LE Henke, JD Pfeifer, C Ma, SM Perkins… - Cancer …, 2015 - Wiley Online Library
The BRAF mutation occurs commonly in papillary thyroid carcinoma (PTC). Previous
investigations of its utility to predict recurrence‐free survival (RFS) and disease‐specific …
investigations of its utility to predict recurrence‐free survival (RFS) and disease‐specific …
相关搜索
- prognostic value thyroid cancer
- recurrence of papillary thyroid cancer
- surgical treatment thyroid carcinoma
- tumor aggressiveness thyroid cancer
- higher rate braf mutation
- clinicopathologic implications thyroid cancer
- subgroup analysis thyroid cancer
- lymphatic mapping thyroid carcinoma
- survival of patients thyroid carcinoma
- clinicopathological features thyroid carcinoma
- japanese population thyroid carcinoma
- consecutive cases thyroid carcinoma
- association of braf v600e mutation
- braf gene mutation
- prognostic value of braf mutation
- surgical treatment braf mutation